AFP and intrahepatic cholangiocarcinoma: Our study combined CYFRA21–1 with traditional differential diagnostic indicators (sex, jaundice, hepatitis, Log AFP, and Log CA19–9) to increase the accuracy and specificity of differentiating ICC from HCC and developed a nomogram that achieved greater benefit than did previous models, potentially aiding in therapeutic decision-making.